EU animal testing
This article was originally published in The Rose Sheet
Executive Summary
Parliament scheduled to debate proposed animal testing ban on cosmetics Jan. 15. Debate will mark Parliament's third reading of the Seventh Amendment to the Cosmetics Directive, but first time legislators have reviewed the proposal since Parliament and Council of Ministers reached a compromise on the text in November (1"The Rose Sheet" Nov. 25, 2002, p. 6). Legislation imposes six-year deadline for halt of animal testing for cosmetics or marketing of cosmetics tested on animals with a 10-year deadline applicable to three tests for which no alternatives are now in development. Ban would be contingent on development, validation of alternatives within Organization for Economic Cooperation and Development. Legislation contingent on approval by Parliament, Council...
You may also be interested in...
EU Animal Testing Labeling Guidelines For Cosmetics To Be Adopted
The European Commission, in collaboration with European Union member states, will develop guidelines to ensure that common criteria are applied to animal testing labeling claims, according to the conciliation agreement of the Seventh Amendment to the Cosmetics Directive released Nov. 15
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.